BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9845964)

  • 1. Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1844-5. PubMed ID: 9845964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automatic system for the assay of guanidino compounds to assess uremic status.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T; Watanabe M
    Biol Pharm Bull; 2000 Sep; 23(9):1015-20. PubMed ID: 10993196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
    Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanidino compounds in uraemic dialysed patients.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
    Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic renal failure and guanidino compounds].
    Kinoshita T
    Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An automated technique for the analysis of plasma guanidino acids, and some findings in chronic renal disease.
    Shainkin R; Berkenstadt Y; Giat Y; Berlyne GM
    Clin Chim Acta; 1975 Apr; 60(1):45-50. PubMed ID: 236102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiautomated method for measurement of guanidinosuccinic acid in serum.
    Kamoun PP; Pleau JM; Man NK
    Clin Chem; 1972 Apr; 18(4):355-7. PubMed ID: 5012258
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
    Maejima M; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
    Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.
    Kopple JD; Gordon SI; Wang M; Swendseid ME
    J Lab Clin Med; 1977 Aug; 90(2):303-11. PubMed ID: 886215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic analysis of guanidino compounds using ninhydrin reagent. II. Guanidino compounds in blood of patients on haemodialysis therapy.
    Hiraga Y; Kinoshita T
    J Chromatogr; 1985 Aug; 342(2):269-75. PubMed ID: 4055949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis].
    Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P
    J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657
    [No Abstract]   [Full Text] [Related]  

  • 15. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
    Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
    Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential removal of guanidinosuccinic acid and creatine by hemodialysis and continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Billiouw JM; Becaus I; Lornoy W
    Nephron; 1991; 57(3):369-70. PubMed ID: 2017282
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guanidino compounds and aliphatic monoamines in acute and chronic renal failure].
    Suzuki Y
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1077-85. PubMed ID: 1289608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathobiochemistry of uremia and hyperargininemia further demonstrates a metabolic relationship between urea and guanidinosuccinic acid.
    Marescau B; De Deyn PP; Qureshi IA; De Broe ME; Antonozzi I; Cederbaum SD; Cerone R; Chamoles N; Gatti R; Kang SS
    Metabolism; 1992 Sep; 41(9):1021-4. PubMed ID: 1518417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of guanidinosuccinic acid by hemodialysis.
    Perez G; Abraira C; Rey A; Horn M
    Nephron; 1977; 19(4):214-9. PubMed ID: 917168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostaglandin metabolism in blood platelets and guanidine level in patients with chronic uremia].
    Komarnicki M; Pietrzak I; ZozuliƄska M; Czarnecki R; Antoniewicz K; Baczyk K
    Pol Arch Med Wewn; 1984 Nov; 72(5):243-7. PubMed ID: 6535143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.